I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical I..:
Meehyun Ko
;
So Young Chang
;
Soo Young Byun
...
SARS-CoV-2 and COVID-19. , 2021
Link:
https://doi.org/10.3390/v13040651
RT Journal T1
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
UL https://suche.suub.uni-bremen.de/peid=base-ftmdpi:oai:mdpi.com:_1999-4915_13_4_651_&Exemplar=1&LAN=DE A1 Meehyun Ko A1 So Young Chang A1 Soo Young Byun A1 Aleksandr Ianevski A1 Inhee Choi A1 Anne-Laure Pham Hung d'Alexandry d'Orengiani A1 Erlend Ravlo A1 Wei Wang A1 Magnar Bjørås A1 Denis E. Kainov A1 David Shum A1 Ji-Young Min A1 Marc P. Windisch PB Multidisciplinary Digital Publishing Institute YR 2021 K1 Middle East respiratory syndrome coronavirus K1 severe acute respiratory syndrome coronavirus disease K1 clinical isolate K1 high-content screening K1 FDA-approved drugs K1 drug repurposing K1 drug combinations K1 lung organoids K1 COVID-19 K1 pandemic JF SARS-CoV-2 and COVID-19 LK http://dx.doi.org/https://doi.org/10.3390/v13040651 DO https://doi.org/10.3390/v13040651 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)